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Abstract  
Objectives 
Higher or lower blood pressure may relate to cognitive impairment, while the relationship 
between blood pressure and cognitive impairment among the elderly is not well-studied. The 
study objective was to determine whether blood pressure is associated with cognitive 
impairment in the elderly, and, if so, to accurately describe the association. 
Design 
Cross-sectional data from the sixth wave of the Chinese Longitudinal Healthy Longevity 
Survey (CLHLS) conducted in 2011 
Setting 
Community-based setting in longevity areas in China 
Participants 
7,144 Chinese elderly aged 65 years and older were included in the sample 
Measures 
Systolic blood pressures (SBP) and diastolic blood pressures (DBP) were measured, pulse 
pressure (PP) was calculated as (SBP)-(DBP) and mean arterial pressures (MAP) was 
calculated as 1/3(SBP) + 2/3(DBP). Cognitive function was assessed via a validated Mini-
Mental State Examination (MMSE). 
Results 
Based on the results of generalized additive models (GAMs), U-shaped associations were 
identified between cognitive impairment and SBP, DBP, PP and MAP. The cut-points at 
which risk for cognitive impairment (MMSE<24) was minimized were determined by 
quadratic models as 141 mmHg, 85 mmHg, 62 mmHg and 103 mmHg, respectively. In the 
logistic models, U-shaped associations remained for SBP, DBP, and MAP but not PP. Below 
the identified cut-points, each 1mmHg decrease in blood pressure corresponded to 0.7%, 
1.1%, and 1.1% greater risk in the risk of cognitive impairment, respectively. Above the cut-
points, each 1mmHg increase in blood pressure corresponded to 1.2%, 1.8%, and 2.1% 
greater risk of cognitive impairment for SBP, DBP and MAP, respectively. 
Conclusion 
A U-shaped association between blood pressure and cognitive function in an elderly Chinese 
population was found. Recognition of these instances is important identifying the high-risk 
population for cognitive impairment and to individualize blood pressure management for 
cognitive impairment prevention. 
Keywords: blood pressure, hypertension, hypotension, cognitive impairment, curvilinear 
association, elderly 
 
  
Introduction 
Hypertension and hypotension are important risk factors for vascular diseases, which may 
lead to cognitive impairment due to stroke or chronic cerebral hypoperfusion in the elderly 
[1]. This suggests that hypertension and hypotension may both be associated with cognitive 
impairment, a common neurological disorder in the elderly. 
In recent years, the link between blood pressure, including systolic blood pressures (SBP) and 
diastolic blood pressures (DBP), to cognitive function has attracted much attention, but the 
role of blood pressure in cognitive impairment is still unclear [2±14]. Several studies reported 
a linear association between elevated blood pressure and increased risk of cognitive 
impairment or dementia [2, 3], and low blood pressure was related to higher risk of dementia 
in the elderly [4, 5]. Additionally, antihypertensive medicines have a valuable role in the 
prevention of dementia or cognitive impairment [6, 7], while some studies failed to confirm 
this association [8, 9]. 
One proposed explanation for inconsistencies among these studies is that the relationship 
between blood pressure and cognitive function is nonlinear. Several investigators have 
demonstrated a U-shaped relationship [10±14] or a J-shaped association between cognitive 
function and blood pressure [4]. Most related researches use linear model including 
multivariate regression model [12,15], hierarchical linear model [14,16], mixed-effects 
regression analyses[11] to examine the possible relations. Few studies use splines to 
determine presence and type of the curvilinear relationships [17]. None of the curvilinear 
associations were demonstrated using generalized additive models (GAMs) and quadratic 
models, whose strengths include the ability to determine the natural shape of the relationship, 
sensitivity to detect non-linear relationships and identifying the optimal cut-points between 
dependent and predictor variable(s). 
Combined measures such as pulse pressure (PP) or mean arterial pressure (MAP) may be a 
salient blood pressure index in the elderly[18] as SBP continuously increases and DBP 
continuously decreases after age 60[19]. Notably, PP and cognitive function have not been 
extensively studied, with positive associations with cognitive impairment being reported in 
some [20±23] but not all [24] studies. Some studies suggest that MAP may be a more 
accurate predictor than other blood pressure indices [25, 26]. 
It is important to clarify whether blood pressure is associated with cognitive impairment in 
the elderly, and, if so, to accurately describe the association. In the present study, we 
investigated the relationship between blood pressure (as measured by SBP, DBP, PP and 
MAP) and cognitive impairment among Chinese elderly, and the possibility of a linear or 
curvilinear relationship using GAMs and quadratic models. 
 
 
Methods 
Study population 
A sample of 7144 elderly aged 65 years and older was included in the sixth wave of the 
Chinese Longitudinal Healthy Longevity Survey (CLHLS) conducted in 2011. The details of 
the CLHLS and sample design have been described elsewhere[27,28]. Informed consent was 
obtained from all participants and/or their relatives, and the study was approved by the Ethics 
Committee of Peking University. 
Assessment of cognitive function 
Cognitive function was assessed by the Mini-Mental State Examination (MMSE) [29], which 
has been widely applied in epidemiological studies. Five domains of cognitive function were 
included, namely orientation, registration, attention, memory, language and visual 
construction skills [30]. The scores ranged from 0 to 30 points, and cognitive impairment was 
identified if the MMSE score was less than 24 [31]. 
Assessment of blood pressure 
After having rested for 5 minutes under supervision of trained research assistants, arterial 
blood pressure was measured with a mercury sphygmomanometer on the right arm at heart 
level of the seated subject. In our analysis, the mean value of two blood pressure 
measurements was calculated and used for further analyses. PP was calculated as (SBP)-
(DBP) and MAP was calculated as 1/3(SBP) + 2/3(DBP). Hypertension was defined as 
syVWROLFEORRGSUHVVXUHPP+JDQGRUGLDVWROLFEORRGSUHVVXUHPP+J 
Assessment of covariates 
Covariates were collected by a structured questionnaire, one part is sociodemographic 
characteristics including age, sex, educational background and residence; the other part is 
health characteristics including physical activity, measured waist circumference, and self-
reported diabetes mellitus, cardiovascular diseases and stroke and other cerebrovascular 
diseases. Age and education were two of the most important confounders in the analysis of 
association between cognitive impairment and blood pressure, and were modeled as 
continuous variables in years. Residence was categorized as urban or rural. Physical activity 
ZDVFODVVLILHGLQWR³\HV´RU³QR´E\WKHTXHVWLRQ³'R\RXRIWHQSDUWLFLSDWHLQSK\VLFDO
DFWLYLWLHVLQFOXGLQJZDONLQJSOD\LQJEDOOUXQQLQJDQG4LJRQJ"´1RQ-stretchable tape was 
used to measure waist circumference at a level between the lowest rib and iliac crest. Central 
obesity was identified if WKHSDUWLFLSDQW¶VZDLVWFLUFXPIHUHQFHZDVFPLQPHQRUFP
in women. 
Statistical analyses 
Generalized additive models were performed to explore the linear or curvilinear association 
between SBP, DBP, PP, MAP and odds of having cognitive impairment. GAMs establish a 
relationship between the mean of a dependent variable and a smoothed (non-parametric) 
function of the predictor variable(s) via a link function. As GAM analysis suggested U-
shaped associations between SBP, DBP, PP, MAP and risk of cognitive impairment on the 
basis of smoothed curve (Figure 1), quadratic regression was performed predicting risk of 
cognitive impairment: Pr(Cognitive impairment|Blood pressure) = {1+exp[-Įȕ1(Blood 
SUHVVXUHȕ2(Blood pressure)2]}íZLWKPRGHOVSDUDPHWHUVĮȕ1 DQGȕ2 estimated using 
PD[LPXPOLNHOLKRRGPHWKRGV,Iȕ1 DQGȕ2 are both non-zero and statistically significant, then 
the estimated level of blood pressure at which risk of cognitive impairment is minimized is -
ȕ1ȕ2). These values are used as cut-points of blood pressure for further analysis. For SBP, 
'%333DQG0$3WKHȕ1 ZHUHHVWLPDWHGDVíííDQGí
UHVSHFWLYHO\DQGWKHȕ2 were estimated as 0.00028, 0.00059, 0.00029 and 0.00064 
respectively; all p values were less than 0.01. The blood pressure values associated with 
lowest risk were identified as 141 mm Hg, 85 mm Hg, 62 mm Hg and 103 mm Hg for SBP, 
DBP, PP and MAP, respectively. For each blood pressure measure, subjects were divided 
into 4 groups, first based on whether they were above or below the cut-point for that measure, 
and within these 2 groups whether they were above or below the mean value of that measure. 
Thus, subjects were first stratified into two groups by cut-points of each blood pressure index 
(values noted above); subjects in the low group were then divided into two sub-groups 
(denoted low and medium-low) using medians of each index (127mm Hg, 77 mm Hg, 49 mm 
Hg, 93 mm Hg for SBP, DBP, PP and MAP, respectively) and subjects in the high group 
were divided into two sub-groups (denoted high and medium-high) using the medians of each 
index (155mm Hg, 90 mm Hg, 73 mm Hg, 110 mm Hg for SBP, DBP, PP and MAP 
respectively). 
Then logistic regression models were performed to assess the risk of cognitive impairment 
with SBP, DBP, PP and MAP as continuous or binary predictor variables below and above 
the cut-points. In a basic model, we adjusted for demographic variables including age, 
gender, years of education, and residence, and further adjusted for physical activity, central 
obesity, diabetes mellitus, cardiovascular diseases, stroke and cerebrovascular diseases in the 
final model. Odds ratios (ORs) with 95% confidence intervals (CIs) in logistic regression 
models were presented. SAS 9.2 (SAS Institute Inc., Cary, NC) was used for all analyses. 
Description of population 
The age of 7,144 participants ranged from 65 to 115 years, with an average of 87 years; 55% 
of participants were female. The mean SBP, DBP, PP and MAP were 135.5, 80.1, 55.4 and 
98.6 mm Hg, respectively; 42.3% of participants had hypertension (Table 1). The average 
MMSE score was 21.1, and prevalence of cognitive impairment was 38.5% (27.8% for men 
and 47.3% for women). The participants who were men, living in urban areas, participating in 
physical activity, and with cardiovascular diseases were less likely to be cognitively 
impaired. The participants with type 2 diabetes or stroke and cerebrovascular diseases were 
more likely to be cognitively impaired (Table 1). The prevalence of hypertension or blood 
pressure measures was not significantly different in those with and without cognitive 
impairment. 
Associations between blood pressure and cognitive impairment 
The results of GAMs and quadratic models suggested a U-shaped association between SBP, 
DBP, PP, and MAP and cognitive impairment. Logistic models were consistent with the U-
shaped associations between cognitive impairment and SBP, DBP, and MAP; however, such 
an association was not apparent for PP, regardless of considering PP as a continuous or 
categorical variable. 
SBP and cognitive impairment 
Among the participants whose SBP levels were below the cut-point (141 mm Hg), there was 
a trend towards significantly decreasing risk of cognitive impairment with increasing levels 
of SBP; each 1mm Hg lower SBP corresponded to a 1.4% higher risk of cognitive 
impairment before adjustment (OR, 1.014; 95% CI, 1.009±1.019). The risk attenuation 
remained significant after adjusting for covariates in the basic and final models, which 
decreased to 0.8% (OR, 1.008; 95% CI, 1.003±1.014) and 0.7% (OR, 1.007; 95% CI, 1.002±
1.013) respectively (Table 2). Participants whose SBP levels were below the cut-point were 
stratified into two equal-sized groups, the univariate analysis showed that the low SBP group 
had higher risk of cognitive impairment compared to medium-low SBP group (OR, 1.25; 
95% CI, 1.12±1.41). The multivariate OR (95% CI) reported in the basic model was 1.15 
(1.00±1.32) and in the final model was 1.18 (1.02±1.35) (Table 3). 
In contrast with findings below the cut-points, the risk of cognitive impairment was greater 
with each higher unit of SBP among the participants whose SBP levels were above the cut-
points. Each 1mm Hg higher SBP corresponded to a 1.2% greater risk of cognitive 
impairment in the univariate and multivariate models (Table 2). Compared with medium-high 
SBP group, participants with high SBP level had a 23% higher risk of cognitive impairment 
in the final model (OR, 1.23; 95% CI, 1.02±1.49) (Table 3). 
DBP and cognitive impairment 
Similar to the relationship seen for SBP, for DBP below the cut-points of 85 mm Hg the 
increased risk of cognitive impairment was also found with lower DBP, there was a 1.1% 
greater risk of cognitive impairment with each 1mm Hg lower DBP after full adjustment 
(OR, 1.011; 95% CI, 1.003±1.020). Compared with medium-low DBP group, participants 
with low DBP levels had a 33% higher risk of cognitive impairment before adjustment (OR, 
1.33; 95% CI, 1.19±1.49), and the association remained after the adjustment. 
Above the cut-point of 85 mm Hg, when DBP was taken as a continuous variable, there was a 
1.8% greater risk of cognitive impairment with each 1mm Hg increment of DBP before 
adjustment and full adjustment (Table 2). When higher DBP was stratified into two equal 
groups, participants with high DBP levels had a 24% higher risk of cognitive impairment 
compared with medium-high DBP group in the final model (OR, 1.24; 95% CI, 1.02±1.52). 
PP and cognitive impairment 
Although we found a U-shaped association between cognitive impairment and PP in the 
GAMs models (Figure 1), quadratic models and as a continuous variable in the univariate 
logistic model, it was non-significant based on multivariate logistic regression (Table 
2, Table 3). 
MAP and cognitive impairment 
As shown in GAMs and in quadratic models, the U-shaped association was confirmed in the 
logistic regression model, that is, each 1 mm Hg lower MAP corresponded to a 1.1% greater 
risk in cognitive impairment below the cut-points of 103 mm Hg, and each 1 mm Hg higher 
MAP corresponded to a 2.1% greater risk in cognitive impairment above the cut-points of 
103 mm Hg (Table 2). Poorer cognitive performance was found in those with low MAP level 
compared to those with medium-low MAP level, and in those with high MAP level compared 
to those with medium-high MAP level (Table 3) 
Discussion 
U-shaped association between blood pressure and cognitive impairment 
In this cross-sectional study of 7144 Chinese elderly aged 65 years and older, we observed U-
shaped associations between blood pressure (SBP, DBP, and MAP) and cognitive 
impairment, with extremes of blood pressures associated with poorer cognitive performance 
after controlling for demographic, lifestyle and biological confounding factors. This 
association was less evident for PP as the U-shaped relationship identified in the GAMs, 
quadratic models and univariate logistic models, Previous studies have provided inconsistent 
results, indicating linear, J-shaped or no association [2±9]. Notably, one proposed explanation 
was that linear function based on experience rather than the natural shape between blood 
pressure and cognitive impairment may not adequately describe the association. 
Several previous reports are consistent with our finding of a U-shaped association of blood 
pressure with cognitive impairment or dementia [10±14]. In a cross-sectional study conducted 
in a biracial community, the highest cognitive function scores were found in the elderly aged 
65 and older whose SBP was at the mean of 140 mm Hg, or in the persons whose DBP was at 
the mean of 77 mm Hg [10]. Similarly, this phenomenon was also confirmed in a 9-year 
longitudinal study in which a U-shaped association with higher risk of cognitive impairment 
DPRQJLQGLYLGXDOVZLWKKLJKHUPP+JDQGORZHU6%3PP+JDVZHOODV
KLJKHU'%3PP+JDQGORZHU'%3PP+J>12]. This was somewhat consistent 
for the very elderly, aged 75 and older, where SBP was significantly associated with MMSE 
in a U-shaped fashion and there was also a linear relationship with PP but no association with 
DBP [13]. What is distinctive in the current study is that it includes a large sample of the very 
elderly, and applies GAMs and the quadratic models identify cut-points that more naturally 
describe the shape of the relationship between blood pressure and cognitive impairment. 
High PP in older adults is recognized as a marker of increased artery stiffness and widespread 
atherosclerosis [32], and may lead to decreased perfusion of the cerebral white matter and 
ultimately increase the risk for cognitive impairment as seen in some previous studies [21±
23]. A U-shaped association between PP and cognitive impairment found in a previous study 
[20], was also found in GAMs, quadratic models and univariate logistic models, but not 
confirmed when logistic models were further performed in our study. 
It has been speculated that low or high blood pressure may be an early manifestation of the 
same pathological changes that lead to cognitive impairment, that is, damage to the brain 
regions that regulate blood pressure [33]. The association between blood pressure and 
cognitive impairment is problematic, and may be an effect of intermediate confounding 
factors affecting both blood pressure and cognitive performance such as weight loss and 
dietary change [34,35], or an effect of shared risk factors such as psychological stress and 
oxidative stress [36±38]. Another hypothesis is the healthy survivor bias. Probably, some 
people whose blood pressure was too low or too high had died before aged 65 years due to a 
window of susceptibility to related diseases (such as hemorrhagic or ischemic stroke) in 
middle age, thus, the elderly in our study were a selected middle blood pressure population 
whose health status was better, including a better cognitive performance. 
Notably, the explanations and mechanisms of how both higher blood pressure and lower 
blood pressure impairs cognitive function are likely to be different. 
High blood pressure was associated with cognitive impairment 
The association between hypertension and cognitive performance may be atherosclerosis, 
cerebral hypoperfusion and white matter lesions [39±43]. Hypertension is a powerful risk 
factor for atherosclerosis throughout the arterial tree [40], which leads to redistribution of 
blood flow and further decrease in cerebral perfusion [41]. This phenomenon has been shown 
to be exceedingly important for cerebral metabolism and cognition [42]. Additionally, studies 
have indicated relationships between abnormalities of the white matter and hypertension [43], 
and such white matter lesions are frequently associated with cognitive impairment [42]. 
Abnormalities of the renin angiotensin system have also been involved in the pathogenesis of 
both hypertension and cognitive impairment. Also, in recent years antihypertensive drugs 
have been used in the treatment and preveQWLRQRI$O]KHLPHU¶VGLVHDVHYLDWKHUHQLQ-
angiotensin system [44]. It is also hypothesized that hypoperfusion-hypoxia might accelerate 
cognitive impairment through inducing expression of vasoactive mediators such as nitric 
oxide, hypoxia-inducible-factor-ĮDQGYDVFXODUHQGRWKHOLDOJURZWKIDFWRU>45]. 
Low blood pressure was associated with cognitive impairment 
For obvious reasons, low blood pressure can cause cerebral hypoperfusion [46]. It had also 
been argued that decline in blood pressure may reduce the velocity of cerebral blood flow, 
which can further cause damage to neural tissue and add to the pathological mechanisms of 
cognitive impairment. Reduced cerebral blood flow has been found both in individuals with 
dementia and in those showing early signs of dementia [46, 47]. Furthermore, it has been 
proposed that severe atherosclerosis resulting from long-standing low blood pressure in 
midlife and later-life may lead to cerebral hypoperfusion, which may be two biological 
pathways [48]. The review by Duschek and colleagues suggested the mechanisms of 
hypotension for reducing cognitive performance include diminished cortical activity, 
deficient regulation of cerebral blood flow in persons with low blood pressure, and 
insufficient adjustment of blood flow to cognitive requirements [49]. However, most studies 
focus on possible mechanisms of cognitive impairment caused by low blood pressure; we 
KDYHQ¶WIRXQGrelated researches on the mechanism of lower blood pressure within the 
normotensive range. 
Limitations 
Our study has several limitations. First, it is not possible to assess the direction of the 
association since both exposure and outcome are assessed simultaneously. Second, the blood 
pressure measurement took place at a single visit and missing data on use of antihypertensive 
medications may diminish the data accuracy. Third, our findings may not be applicable to 
younger populations because CLHLS over-sampled the oldest-old and dynamics of blood 
pressure changes with age. Finally, weight loss and dietary change, psychological stress and 
an oxidative stress may be confounding factors, but they were not measured and controlled in 
this study. 
Conclusions 
Our results suggest a U-shaped association between blood pressure (including SBP, DBP, 
MAP) and cognitive functions, that is, both higher and lower levels of blood pressure were 
associated with higher risk of cognitive impairment, which may have several implications for 
clinical practice and cognitive impairment prevention. First, both lower and higher blood 
pressure may be used to identify the high-risk population for cognitive impairment. 
Furthermore, it may point to the need to individualize blood pressure management for 
cognitive impairment prevention, that is, we should not only address blood pressure-lowering 
therapy in elderly with hypertension, but may also focus on raising blood pressure in elderly 
with relatively lower blood pressure. Future prospective longitudinal studies with blood 
pressure monitoring and extensive cognitive testing are needed to confirm the association we 
found in this study. 
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Table 1 
Characteristics of 7,144 Chinese elderly by cognitive status, 2011 
Factors* 
Normal 
cognition 
n=4393 
Cognitive 
impairment 
n=2751 
Total 
n=7144 P-value 
MMSE 26.8(2.3) 9.2(6.7) 21.1(10.9) <0.0001 
Age (year) 83.3(9.7) 93.2(9.7) 87.1(10.9) <0.0001 
Gender 
    
  Male 2335(46.9) 900(32.7) 3235(45.3) <0.0001 
    Female 2058(53.1) 1851(67.3) 3909(54.7) 
 
Residence 
    
    Urban 2226(59.8) 1464(53.2) 4430(57.2) <0.0001 
    Rural 1787(40.2) 1287(46.8) 3054(42.8) 
 
Education (year) 3.2(3.0) 1.1(2.5) 2.4(3.6) <0.0001 
Physically active 2100(48.0) 671(24.5) 2771(39.0) <0.0001 
Good visual function 3749(85.3) 1577(57.3) 5326(74.6) <0.0001 
Central obesity 2198(50.0) 1102(40.1) 3300(46.2) <0.0001 
Diabetes mellitus 248(5.9) 92(3.7) 340(5.1) <0.0001 
Cardiovascular diseases 653(15.5) 324(12.8) 977(14.5) 0.0024 
Stroke and cerebrovascular 
diseases 
332(7.9) 265(10.4) 597(8.8) 0.0004 
Systolic blood pressure 
(mmHg) 
135.7(19.4) 135.2(22.0) 135.5(20.4) 0.3055 
Diastolic blood pressure 
(mmHg) 
80.3(11.2) 79.8(12.9) 80.1(11.9) 0.1302 
Pulse pressure (mmHg) 55.4(15.9) 55.4(17.5) 55.4(16.6) 0.8600 
Mean arterial 
pressure(mmHg) 
98.8(12.3) 98.3(14.3) 98.6(13.1) 0.1494 
Hypertension 1859(42.3) 1162(42.2) 3021(42.3) 0.9481 
*Dichotomous variables listed as n (%), including gender, current smoking practice, alcohol 
drinking habits, central obesity, diabetes, cardiovascular diseases, stroke and cerebrovascular 
diseases, hypertension, were compared between two cognitive status groups using Chi-square 
tests; Continuous variables listed as mean (standard deviation), including age, education, 
6%3'%3330$3ZHUHFRPSDUWHGEHWZHHQWZRJURXSVXVLQJ6WXGHQW¶V7WHVWVRU
Cochran-Cox tests. MMSE, Mini Mental State Examination. 
  
Table 2 
Logistic odds ratio (95% Confidence Intervals) for cognitive impairment and continuous 
measures of blood pressure among Chinese elderly. 
Variables Unadjusted Basic modelÁ Final model§ 
Each 1mmHg lower in 
participants with SBP 
<141mmHg (n=4733) 
1.014(1.009±
1.019)  
1.008(1.003±
1.014)  
1.007(1.002±
1.013)  
Each 1mmHg higher in 
participants with SBP 
PP+JQ  
1.012(1.006±
1.017)  
1.010(1.004±
1.017)  
1.012(1.005±
1.019)  
Each 1mmHg lowerin 
participants with 
DBP<85mmHg (n=5180) 
1.023(1.015±
1.030)  
1.011(1.003±
1.019)  
1.011(1.003±
1.020)* 
Each 1mmHg higherin 
participants with DBP 
PP+JQ  
1.018(1.007±
1.028)  
1.021(1.009±
1.033)  
1.018(1.006±
1.030)  
Each 1mmHg lower in 
participants with 
PP<62mmHg (n=5111) 
1.013(1.007±
1.20)  
1.008(1.001±
1.015)* 
1.008(1.000±
1.015)* 
Each 1mmHg higherin 
participants with 
33PP+JQ  
1.009(1.002±
1.017)* 
1.002(0.994±
1.011) 
1.005(0.996±
1.013) 
Each 1mmHg lower in 
participants with 
MAP<103mmHg (n=4792) 
1.022(1.014±
1.029)  
1.012(1.004±
1.021)  
1.011(1.003±
1.020)* 
Each 1mmHg higher in 
participants with 
0$3PP+JQ  
1.021(1.012±
1.030)  
1.022(1.012±
1.033)  
1.021(1.011±
1.032)  
*p<0.05 
p<0.01. 
ÁAdjusted for demographic variables including age (year), gender, education level (year), 
residence in basic model, 
§Further adjusted physical activity, vision, waist circumference, type 2 diabetes mellitus, 
cardiovascular diseases and stroke and cerebrovascular diseases in final model. 
DBP diastolic blood pressure; MAP mean arterial pressure, PP pulse pressure, SBP systolic 
blood pressure. 
  
Table 3 
Logistic odds ratio (95 % confidence intervals) for cognitive impairment and blood pressure 
categories among Chinese elderly. 
Variables Unadjusted Basic modelÁ Final model§ 
SBP 
   
  Low(SBP<127mmHg, n=2324) 1.25(1.12±
1.41) 
1.15(1.00±
1.32)* 
1.18(1.02±
1.35)* 
  Medium-ORZ6%3PP+J
n=2409) 
1.00 reference 1.00 reference 1.00 reference 
  Medium-KLJK6%3PP+J
n=1284) 
1.00 reference 1.00 reference 1.00 reference 
  +LJK6%3PP+JQ  1.21(1.02±
1.42)* 
1.18(0.99±
1.42) 
1.23(1.02±
1.49)* 
DBP 
   
  Low(DBP<77mmHg, n=2536) 1.33(1.19±
1.49) 
1.20(1.05±
1.36) 
1.20(1.05±
1.37) 
  Medium-ORZ'%3PP+J
n=2644) 
1.00 reference 1.00 reference 1.00 reference 
  Medium-+LJK'%3PP+J
n=989) 
1.00 reference 1.00 reference 1.00 reference 
  +LJK'%3PP+JQ  1.26(1.07±
1.50) 
1.26(1.04±
1.52)* 
1.24(1.02±
1.52)* 
PP 
   
  Low(PP<49mmHg, n=2523) 1.18(1.05±
1.32) 
1.08(0.95±
1.23) 
1.09(0.95±
1.25) 
  Medium-ORZ33PP+J
n=2588) 
1.00 reference 1.00 reference 1.00 reference 
  Medium-KLJK33PP+J
n=1035) 
1.00 reference 1.00 reference 1.00 reference 
  +LJK33PP+JQ  1.04(0.87±
1.24) 
0.90(0.74±
1.10) 
1.04(0.84±
1.28) 
Variables Unadjusted Basic modelÁ Final model§ 
MAP 
   
  Low(MAP<93mmHg, n=2560) 1.31(1.17±
1.48) 
1.15(1.00±
1.33) 
1.15(1.00±
1.34)* 
  Medium-ORZ0$3PP+J
n=2232) 
1.00 reference 1.00 reference 1.00 reference 
  Medium-KLJK0$3PP+J
n=1 186) 
1.00 reference 1.00 reference 1.00 reference 
  +LJK0$3PP+JQ  1.21(0.99±
1.33) 
1.20(0.99±
1.44) 
1.22(1.01±
1.48)* 
*p<0.05 
p<0.01. 
ÁAdjusted for demographic variables including age (year), gender, education level (year), 
residence in basic model, §Further adjusted physical activity, vision, waist circumference, 
type 2 diabetes mellitus, cardiovascular diseases and stroke and cerebrovascular diseases in 
final model. 
DBP diastolic blood pressure; MAP mean arterial pressure, PP pulse pressure, SBP systolic 
blood pressure. 
Figure 1 
Smoothing component for cognitive impairment 
Legends: Associations of SBP, DBP, PP and MAP with cognitive impairment for the elderly, 
Chinese Longitudinal Healthy Longevity Survey, China, 2011. The lines depict the estimated 
function of SBP, DBP, PP and MAP respectively, for risk of cognitive impairment among the 
elderly, and the shaded area indicates the 95% confidence intervals. 
SBP, Systolic blood pressure; DBP, diastolic blood pressures; PP, pulse pressure; MAP, 
mean arterial pressure. 
 
